Treatment success rate · women with CSP
UAE/UACE showed no clear difference in treatment success after initial treatment UAE vs systemic MTX compared with systemic MTX (low certainty).
1 finding from 1 review
Time to normalize β‐hCG after UAE · women with CSP
1 finding from 1 review
Complications UAE vs systemic MTX · women with CSP
UAE/UACE showed no clear difference in complications UAE vs systemic MTX compared with systemic MTX (low certainty).
1 finding from 1 review
Adverse effects UAE vs systemic MTX · women with CSP
UAE/UACE showed no clear difference in adverse effects UAE vs systemic MTX compared with systemic MTX (low certainty).
1 finding from 1 review
Blood loss UAE vs systemic MTX · women with CSP
1 finding from 1 review
Time to normalize β‐hCG · women with CSP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success after initial treatment after UAE · women with CSP
It is very uncertain whether suction curettage under hysteroscopy changes treatment success after initial treatment after UAE compared with under ultrasonography (very low certainty).
1 finding from 1 review
Complications after UAE · women with CSP
It is very uncertain whether suction curettage under hysteroscopy changes complications after UAE compared with under ultrasonography (very low certainty).
1 finding from 1 review
Adverse effects after UAE · women with CSP
It is very uncertain whether suction curettage under hysteroscopy changes adverse effects after UAE compared with under ultrasonography (very low certainty).
1 finding from 1 review
Blood loss · women with CSP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Frequency of skin damage (as recorded by clinicians according to STAR Skin Tear Classification) Outcome measured during 6 months · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Side effects from intervention (as and when observed) Outcome measured up to day 56 ± 4 · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Transepidermal water loss (TEWL) Measured using temperature‐adjusted g/m²/h with the Tewameter TM 300 (Courage + Khazaka, Cologne, Germany) Hahnel 2017: measured at 56 ± 4 days Shishido 2017: measured 15 minutes after wiping the skin with a dry to... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Stratum corneum hydration (SCH) (at baseline and day 56 ± 4) Hahnel 2017: measured at 56 ± 4 days in mid‐volar arm and lower leg in arbitrary units from 0 (no water) to 120 (on water) using the Corneometer CM 825 Gillis 2016: measured at 12 weeks ... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Erythema · people 60 years of age and older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Clinical score of dryness Hahnel 2017: measured at day 56 ± 4 using the Overall Dry Skin Score Boccanfuso 1978: measured after 10 applications using a non‐validated General Foot Condition Questionnaire including a Dryness Scale (1 = oily; 2 = norm... · people 60 years of age and older
1 finding from 1 review
Intervention not reported
Clinical score of itch · people 60 years of age and older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · people with diabetes and foot ulcers
The review found no eligible studies for this question.
2 findings from 1 review
Adverse events · people with diabetes and foot ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Development of any new foot ulcers · people with diabetes and foot ulcers
It is very uncertain whether arginine, glutamine and β‐hydroxy‐β‐methylbutyrate supplement changes development of any new foot ulcers compared with placebo (very low certainty).
1 finding from 1 review